Currently available techniques used in basic research (e.g. pathogenesis studies) will be tested for their application in routine diagnosis of viral diseases, e.g. by molecular hybridisation. Some techniques need to be simplified (e.g. RNA extraction procedures) and, particularly, alternative labelling schedules must be developed (e.g. biotin or sulfone labelling instead of radionuclides).
In the Hanover Institute of Virology, biotechnological methods are used for different purposes. Generally, one can distinguish between basic research dealing with the biology and pathogenicity of viruses, and "applied research" using methods established during basic research for diagnostic and possibly prophylactic means. It will become clear, however, that this distinction is merely schematic and that the borderlines between them are blurred. This paper presents a variety of contributions from the Hanover Veterinary School. Recent and present projects are briefly described in so far as biotechnological methods are involved. A main topic in which we are interested is the question of viral persistence, an increasingly important problem in animal viruses. We are dealing with this subject by studying Aleutian disease (AD) of mink. AD is caused by an autonomous parvovirus (Aleutian disease virus, ADV) and characterised by plasmacytosis, hypergammaglobulinaemia and persistent viraemia. Deposited reactive immune complexes lead to arteritis and glomerulonephritis, eventually leading to death of the infected animal.
Before studying the interaction of virus and host at the cellular level, we investigated the structure and function of the DNA and proteins of ADV as well as the molecular biology of the virus. Therefore we started with cloning of ADV DNA. Since this is a single-stranded DNA, the replicative double-stranded DNA form (Monomer RF DNA) was used (12) . We succeeded in cloning a central 73% fragment in pUC vectors and almost the whole genome in two subgenomic fragments in pTZ vectors. In the first case, ADV specific expression was demonstrated.
This cloned DNA proved to be a useful tool for investigating ADV replication in vitro and in vivo, by using it in nucleic acid hybridisation studies. Thus, replicative DNA forms could be detected by Southern blot hybridisation (12) . Furthermore, ADV replication in blood lymphocytes could be demonstrated by slot blot hybridisation (10) . To investigate the actual replication site(s) of ADV in vivo, in situ hybridisation studies were performed to detect viral DNA in organs of naturally infected mink (8) . This turned out to be more valid than the demonstration of viral antigen, since the presence of viral proteins does not necessarily prove the presence of ADV, but may be due to deposition or phagocytosis of virus. These studies confirmed the lymphotropism of ADV. For some purposes, ADV DNA was labelled nonradioactively with biotin or sulfone. Furthermore, it proved to be useful to apply single-stranded RNA's for hybridisation, which were generated in a dual transcription vector after subcloning the above-mentioned central ADV DNA fragment.
In addition, studies on ADV RNA (transcription) were performed to learn more about genomic organisation, including in vitro translation assays followed by immunoprecipitation. In parallel we have begun to sequence the cloned DNA which will complete the results mentioned above and, by comparison with recently published data for other ADV strains, make it possible to locate conserved as well as variable sequences (the latter probably being related to differences in virulence).
Other studies have dealt with protein components of the virus. ADV possesses two structural as well as one (possibly two) non-structural proteins. These were characterised by epitopic mapping (2D-electrophoresis after specific proteolysis and immuno-blotting). For this purpose, monoclonal antibodies directed against epitopes on the structural and non-structural proteins were produced (11) . Neutralising monoclonal antibodies are now available and will be used to study the mechanism of virus neutralisation, which occurs to a limited extent in vivo, although neutralising antibodies do exist (15) .
Also under study (in cooperation with Professor V. Moennig and Professor B. Liess from our Institute) is the virus of classical swine fever (hog cholera). This is an economically important disease in many pig-breeding countries, It belongs to the genus Pestivirus of the Togaviridae family. Little is known about its protein, nucleic acid and molecular biology. This is partly due to the poor growth of the virus in cell cultures, and partly because a major portion of the virus remains cell-bound, thus rendering its purification difficult. These and other features (e.g. the general absence of cytopathogenicity) hamper virus cultivation for diagnostic purposes. Diagnosis by immunofluorescence (i.e. proof of viral antigen, for instance in tonsils) can be difficult, because the viral antigens tend to be labile (autolysis). An additional problem which can complicate a specific diagnosis is that pigs are susceptible to infection with bovine virus diarrhoea virus (BVDV) which is harmless for them, but which induces antibodies against this virus. Unfortunately, since this virus is related to hog cholera virus, BVDV and the antibodies against it cross-react (and may even cross-neutralise) with hog cholera antibodies and hog cholera.
These facts recently led us to examine the molecular make-up of the virus in order to develop an alternative virus test-system, based on molecular hybridisation, which in general is a useful diagnostic tool (7). The first step was to attempt molecular cloning of the viral nucleic acid. Since the viral genome is a single-stranded RNA of positive polarity, it had to be transcribed into a double-stranded DNA.
The essential reaction steps were:
1. Random priming with oligonucleotides to generate an RNA:DNA hybrid using the reverse transcriptase reaction We succeeded in establishing several clones containing subgenomic fragments which are being tested for suitability for diagnostic hybridisation in RNA samples extracted from infected tissues. Another approach is to try to express virus-specific fusion proteins and to test them for usefulness as diagnostic antigens. The next step is the sequencing of the fragments to reveal the genomic organisation of the RNA, but for that purpose the major part of the genome must be available in cloned fragments. In parallel we would like to develop an analogous diagnostic hybridisation test for the above-mentioned bovine virus diarrhoea virus (BVDV). In contrast to hog cholera virus in swine, this agent is widespread in cattle. The virus induces a wide range of clinical symptoms including diarrhoea, abortion, congenital defects, subclinical or persistent infections (immunotolerance) and mucosal disease. BVDV shows a marked antigenic variation, and both cytopathic (CP) and non cytopathic (NCP) strains exist. Research has concentrated on calves infected in utero at about 150 to 200 days of gestation. These animals may become immunotolerant to the virus, and are born persistently infected (viraemic), shedding the virus but lacking neutralising antibodies. Such animals are of great importance for the epidemiology of bovine virus diarrhoea as well as for research on the pathogenesis of mucosal disease. Persistent infections are often associated with NCP strains.
Serological tests cannot recognise these animals, so virus cultivation is necessary. This takes several days or even two weeks and is hampered by the occurrence of noncytopathogenic strains. Therefore, diagnostic hybridisation could provide a (rapid) alternative. We have received a cloned subgenomic fragment of BVDV cDNA (kindly provided by Dr M. Collett) and are testing the utility of DNA and RNA probes (after subcloning in the transcription vector already mentioned). In addition to these DNA/RNA hybridisation procedures, we intend to use labelled oligonucleotides complementary to certain BVDV RNA regions for comparative hybridisation experiments. These studies may provide some additional information about viral persistence at molecular level.
Finally, in addition to these recombinant DNA technology projects, we have started to test oligopeptides for diagnostic (and probably prophylactic) applications. Normally only a few amino acids determine a specific viral epitope, so the in vitro synthesis of these sequences should be able to mimic the in vivo situation. For this purpose, however, it is necessary to know the nucleic acid sequences (amino acid sequencing of the respective protein being another possibility).
We are using peptide technology to try to establish a serological test system for members of the genus Alphavirus in the Togaviridae family. Prototype viruses are Sindbis virus and Semliki Forest virus, the nucleic acid sequences of which are known. Using the computer-based PRTALN subprogramme of the RBSA {rapid biosequence similarity analysis) programme, we determined the corresponding amino acids and sequence homologies between both viruses. To look for hydrophilic sites, the primary structures were examined by using a HYDRO subprogramme of the DNA-Mount-programme. The data were also used to determine the putative secondary structure of the proteins.
Based on these data, regions with at least ten conserved amino acids, displaying a relatively high hydrophilicity as well as a promising secondary structure, were selected and used (with minor modifications) for the synthesis of three peptides (produced by Biochrom, Berlin, Federal Republic of Germany; Applied Biosystems, Forster City, USA). These peptides were coupled to keyhole limpet haemocyanin (KLH) via meta-maleimido-N-hydroxy-succinimide ester (MBS) or glutaraldehyde, and used to immunise rabbits. All animals developed antibodies against the inoculated peptides. We are presently testing whether these antibodies recognise the proteins of SFV and SV from which the peptide sequences were deduced. A second step would be to discover whether these antibodies possess neutralising activities, which would render these peptides promising candidates for a vaccine.
Monoclonal antibodies (MAB's) are widely used for a number of important applica tions. In this Institute, a panel of MAB's against several pathogens has been developed:
Alphaviruses
The Alphavirus genus of Togaviridae comprises about 27 viruses with varying importance for human and veterinary medicine. All members of the genus are antigenically related.
MAB's were prepared against the nucleocapsid protein of Semliki Forest virus. By using the distantly related Sindbis virus, cross-reacting MAB's were selected. These MAB's were shown to react with most alphaviruses, i.e. with five out of seven antigenic complexes (5) . Another series of broadly cross-reacting antibodies was directed against the envelope proteins of alphaviruses. By using the above-mentioned MAB's, a sensitive assay for the diagnosis of alphaviruses was developed (6).
Pestiviruses
Like alphaviruses, pestiviruses are members of the family Togaviridae. They include three economically important viruses: hog cholera virus, bovine virus diarrhoea virus (BVDV) and Border disease virus of sheep. All pestiviruses share common antigenic determinants and they are able to infect heterologous host animals (2). This creates considerable problems in the proper diagnosis of pestiviral infections.
We prepared MAB's against a conserved, nonstructural protein of pestivirus (14) as well as antibodies against the major envelope protein of hog cholera virus (9) and BVDV (1). By using these MAB's it is possible to make a differential diagnosis of pestiviral antigens in organs of infected animals (16) . Many questions are still open with regard to evolution/variability, epidemiology and pathogenesis of pestivirusinduced diseases. Recently we were able to identify a receptor for BVDV on bovine cells (3) . Heterologous pestiviruses (hog cholera virus and Border disease virus) do not use this receptor when infecting bovine cells. The biological significance of these receptors remains to be elucidated.
Brucella
A major difficulty in the accurate diagnosis of brucellosis is the extensive serological cross-reactivity of Brucella spp. with other Gram-negative bacteria, notably Yersinia enterocolitica 0:9. We were able to establish MAB's reactive with Brucella only, discriminating other Gram-negative bacteria (3, 4) . So far the antibodies have been used to develop fluorescence and enzyme immunoassays for the specific diagnosis of antigen. At present an effort is being made to use the MAB's for developing a diagnostic test which will detect Brucella-specific antibodies in serum of infected animals. This is a cooperative effort with the Central Veterinary Laboratory of the British Ministry of Agriculture. Resumen: Los métodos biotecnológicos ofrecen perspectivas promisorias tanto respecto de mejoras en los diagnósticos como respecto de la profilaxis de las enfermedades animales. En el Instituto de Virología de la Escuela Veterinaria de Hannover se utilizan las técnicas que se enumeran a continuación.
-Producción de anticuerpos monoclonales dirigidos contra antígenos específicos, virales o bacterianos, tales como el virus de la enfermedad mucosa, el virus de la peste porcina clásica, el virus de la leucemia felina, los parvovirus animales, Alphavirus, Brucella y Francisella.
-Establecimiento y mejoras de pruebas inmunoenzimáticas sensibles (ELISA) para el diagnóstico mediante anticuerpos monoclonales.
-Clonación y determinación de secuencias del ARN viral de la peste porcina clásica y del ADN de parvovirus.
-Desarrollo de técnicas de hibridación para el diagnóstico («dot», «slot», Southern y Northern «blot», hibridación in situ, oligonucléotidos).
-Detección de genomas virales en los tejidos de los animales infectados.
-Desarrollo de oligopéptidos sintéticos como antígenos para el diagnóstico y como inmunógenos para las vacunas.
Las técnicas de uso corriente en la investigación pura (por ejemplo, las utilizadas en el estudio de la patogénesis) se someterán a prueba para su aplicación al diagnóstico de rutina de las enfermedades virales, mediante la hibridación molecular, por ejemplo. Habrá que simplificar algunas técnicas (por ejemplo, los métodos de extracción del ARN) y, en particular, establecer otros métodos de marcación (marcación mediante biotina o sulfones en vez de radionucleídos).
PALABRAS CLAVE: Anticuerpos monoclonales -Clonación molecular y determinación de secuencias -Hibridación de ácido nucleico -Oligopéptidos. * * *
